Biotech Food Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Apr
5
2019
FDA Highlights Advances In Animal Biotechnology Product Development Bergeson & Campbell, P.C.
Apr
5
2019
Oklahoma’s Unity Bill Allows Employers to Prohibit Medical Marijuana Use by Employees in Safety-Sensitive Positions Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
5
2019
USDA APHIS Requests Public Comments On dEA And dPPRA Draft Documents Bergeson & Campbell, P.C.
Apr
5
2019
FDA Releases Heavy Metal Test Results in Kratom Keller and Heckman LLP
Apr
4
2019
Federal Circuit Addresses Obviousness of Polymorphs in Grunenthal GmbH v. Alkem Labs. Ltd., No. 2017-1153 (Fed. Cir. Mar. 28, 2019) Polsinelli PC
Apr
4
2019
Medical Marijuana Delivery App Agrees to Settle TCPA Case for $1.75M Robinson & Cole LLP
Apr
4
2019
Cleveland Clinic II – Why Can’t a Diagnostic Conclusion be a Practical Application of a Natural Law? Schwegman, Lundberg & Woessner, P.A.
Apr
4
2019
Washington Court of Appeals Upholds Multi-Million Dollar Fine for 5-Hour Energy Advertising Claims McDermott Will & Emery
Apr
4
2019
FDA Encourages Participation in Voluntary Plant Biotechnology Consultation Program and Revises Guidance on Voluntary Labeling of Foods Derived Plant Biotechnology Keller and Heckman LLP
Apr
4
2019
FDA Updates Guidance for CBD Products amid a New Round of Warning Letters and Announcement of Date for Public Hearing Wilson Elser Moskowitz Edelman & Dicker LLP
Apr
3
2019
340B Drug Ceiling Prices Now Available Dinsmore & Shohl LLP
Apr
3
2019
CMS’s New Part D Policies Address the Opioid Epidemic Mintz
Apr
3
2019
FDA Commissioner Gottlieb Says Agency Will Not Tolerate Deceptive Marketing of CBD Products; Issues Warning Letters Epstein Becker & Green, P.C.
Apr
3
2019
FDA Announces Public Hearing on Products Containing Cannabis or Cannabis-Derived Compounds McDermott Will & Emery
Apr
3
2019
FDA Announces New Steps to Advance Regulatory Framework for CBD Products Keller and Heckman LLP
Apr
2
2019
New Arkansas Law Defines Rice, Beef, Pork, and Meat Keller and Heckman LLP
Apr
2
2019
What is the Deal With TDF Drug and Truvada Lawsuits? Stark & Stark
Apr
2
2019
Federal Circuit Finds Endo Method Of Treatment Claims Satisfy 35 USC 101 Foley & Lardner LLP
Apr
1
2019
Bridging the Weeks by Gary DeWaal: March 18 – 29 and April 1, 2019 (Programmer’s Trial; Trade Reporting Headaches; Food Giants Settle Manipulation Enforcement Action) Katten
Apr
1
2019
FDA Silent on CBD Regulation at Cosmetics Conference, But Legislation May Be Imminent Mintz
Apr
1
2019
District Court Decision Rejects Commerce Clause Challenge to Missouri’s Retailer Wine Shipping Laws McDermott Will & Emery
Apr
1
2019
Public Consultation on EFSA’s Draft Assessment of 5 Phthalates Underway Keller and Heckman LLP
Apr
1
2019
U.S. Supreme Court to Consider Whether Courts Must Defer to an Agency’s Interpretation of its Regulations – a Judicial Policy That Recently Resulted in Dismissal of Litigation Over ‘No Sugar Added’ Claims on 100% Juices Keller and Heckman LLP
Mar
30
2019
Second Circuit Affirms “Snap” Removal Practice Sheppard, Mullin, Richter & Hampton LLP
Mar
29
2019
Endo v. Teva – Correlation Diagnostic Plus Treatment is Patent Eligible under s. 101 Schwegman, Lundberg & Woessner, P.A.
Mar
29
2019
OH SNAP! Supreme Court to Take on Meaning of Key FOIA Exemption Sheppard, Mullin, Richter & Hampton LLP
Mar
29
2019
FDA’s Premarket Voluntary Plant Biotechnology Consultation Program Provides Opportunity For Developers Bergeson & Campbell, P.C.
Mar
29
2019
FDA Announces Enforcement Discretion for Certain Commodities Related to Produce Safety Rule Keller and Heckman LLP
Mar
29
2019
Possession Of A Medical Marijuana Card Alone Does Not Prove Marijuana Use, Appeals Court Holds Jackson Lewis P.C.
Mar
29
2019
ISO Publishes Standard on Matrix of Properties and Measurement Techniques for Graphene and Related 2D Materials Bergeson & Campbell, P.C.
Mar
29
2019
Learned Intermediary Doctrine Protects Pharmacy from Liability for Failure to Warn of Prescription Drug Side Effects Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
28
2019
New Jersey Legislature Cancels Vote to Legalize Recreational Marijuana Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
28
2019
California Jury Awards $80 Million Verdict in Glyphosate Case Keller and Heckman LLP
Mar
28
2019
Pharmacies: DOJ Wins TRO to Immediately Suspend Registration for Controlled Substances Foley & Lardner LLP
Mar
27
2019
FDA’s Evolving “Compliance Policy” for Deemed Tobacco Products: What it Means for Your Business Keller and Heckman LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins